What types of agencies buy Synthetic Biology services?

Federal agencies across all departments procure Synthetic Biology services, including the Department of Defense, Department of Veterans Affairs, General Services Administration, and civilian agencies. State and local governments also issue Synthetic Biology contracts through their own procurement portals.

How do I find Synthetic Biology contracts with SamSearch?

Use SamSearch to browse pre-classified opportunities in one place, with AI-powered filtering by agency, set-aside, and deadline.

Are there set-aside contracts for small businesses in Synthetic Biology?

Yes. Many Synthetic Biology contracts are set aside for small businesses, including 8(a), WOSB, SDVOSB, and HUBZone firms. Use SamSearch's set-aside filters to find contracts your business qualifies for.

How competitive are Synthetic Biology government contracts?

Competition varies by contract size and type. Large IDIQ vehicles in Synthetic Biology can attract dozens of bidders, while small open-market solicitations may have only a few. Monitoring active solicitations and building agency relationships early improves win rates.

Contract Category

Synthetic Biology Government Contracts

6 government contract opportunities classified as Synthetic Biology. Updated daily.

5 federal1 forecastsUpdated daily

Federal Opps

Federal contracts

SLED Opps

—

State, local & education contracts

Forecasts

Agency pipeline forecasts

Total

All sources combined

5 federal contract opportunities classified as Synthetic Biology.

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Advanced Research Projects Agency for Health (ARPA-H) Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) Program

Active

AI Summary

The Advanced Research Projects Agency for Health (ARPA-H) is seeking proposals from small businesses for innovative research and development projects under the SBIR/STTR program. Topics include fertility diagnostics, bioadhesives, toxin removal platforms, non-surgical therapies for endometriosis, and more. Interested p…

Posted Jun 11, 2026Due Jul 10, 2026PresolicitationNAICS 541715Total Small Business Set-Aside (FAR 19.5)Sol: 7599226SN106

View details→

DEPT OF DEFENSE

NON-OPTICAL METHODS FOR HIGH SPEED PROTEIN CONTROL

Active

AI Summary

The Department of Defense's DARPA is seeking innovative solutions for rapidly switchable, non-optogenetic protein domains for real-time cellular control. This initiative aims to develop a versatile molecular tool for massless information transfer across cell membranes, enhancing existing synthetic biology platforms.

Posted Jun 8, 2026Due Dec 8, 2026Special NoticeNAICS 541714Sol: DARPA-SN-26-89

View details→

DEPARTMENT OF ENERGY

TECHNOLOGY/BUSINESS OPPORTUNITY MAXIMIZING RARE EARTH ELEMENT SEPARATION WITH LANMODULIN PROTEIN USING A NOVEL DESORPTION TECHNOLOGY

Archived

AI Summary

Lawrence Livermore National Laboratory is seeking industry partners to commercialize a novel desorption technology for maximizing rare earth element separation using Lanmodulin protein. This opportunity aims to address the growing demand for REEs and improve separation efficiency. Interested companies should submit a s…

Posted Oct 27, 2025Due Nov 28, 2025Special NoticeNAICS 325180Sol: 2025-123

View details→

DEPT OF DEFENSE

RESEARCH AND DEVELOPMENT OF GENOMICS AND SYNTHETIC BIOLOGY

Archived

AI Summary

This opportunity is a pre-solicitation notice for an Indefinite Delivery Indefinite Quantity (IDIQ) contract focused on research and development in genomics and synthetic biology. The contract will be negotiated and has a five-year ordering period, managed by the USACE Engineer Research and Development Center.

Posted Oct 4, 2023Due Sep 6, 2023PresolicitationSol: W912HZ23R0030

View details→

DEPT OF DEFENSE

SBIR OPPORTUNITY: RAPID, FLEXIBLE DE NOVO MANUFACTURING OF DNA MOLECULES FOR SYNTHETIC BIOLOGY AND THERAPEUTIC APPLICATIONS

Archived

AI Summary

The Defense Advanced Research Projects Agency (DARPA) is seeking innovative research concepts for the rapid and flexible manufacturing of DNA molecules applicable to synthetic biology and therapeutic uses. This SBIR opportunity invites submissions that can advance the field significantly.

Posted Sep 17, 2020Due Oct 15, 2020PresolicitationSol: HR001120S0019-16

View details→